Postoperative evaluation of patients with acromegaly: Clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 12, 2005, Pages 6480-6489

  Feelders, R A ^a   Bidlingmaier, M ^b   Strasburger, C J ^c   Janssen, J A M J L ^a   Uitterlinden, P ^a   Hofland, L J ^a   Lamberts, S W J ^a   Van Der Lely, A J ^a   De Herder, W W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; PROTEIN SUBUNIT; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; UNIVERSITY HOSPITAL;

ACROMEGALY; ADULT; AGED; CARRIER PROTEINS; FEMALE; GLUCOSE TOLERANCE TEST; GLYCOPROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 28744446861     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0901     Document Type: Article

References (33)

1. Freda PU 2003 Current concepts in the biochemical assessment of the patient with acromegaly. Growth Horm IGF Res 13:171-184
2. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S 2000 Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529
3. Freda PU, Landman RE, Sundeen RE, Post KD 2001 Gender and age in the biochemical assessment of cure of acromegaly. Pituitary 4:163-171
4. Osman IA, James RA, Chatterjee S, Mathias D, Kendall-Taylor P 1994 Factors determining the long-term outcome of surgery for acromegaly. QJM 87:617-623
5. Kreutzer J, Vance ML, Lopes MB, Laws Jr ER. 2001 Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. J Clin Endocrinol Metab 86:4072-4077
6. Takahashi JA, Shimatsu A, Nakao K, Hashimoto N 2004 Early postoperative indicators of late outcome in acromegalic patients. Clin Endocrinol (Oxf) 60:366-374
7. Kristof RA, Neuloh G, Redel L, Klingmuller D, Schramm J 2002 Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission. J Neurosurg 97:1282-1286
8. Espinosa-de-los-Monteros AL, Mercado M, Sosa E, Lizama O, Guinto G, Lopez-Felix B, Garcia O, Hernandez I, Ovalle A, Mendoza V 2002 Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly. J Neurosurg 97:287-292
9. Baxter RC 1994 Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 42:140-144
10. de Herder WW, van der Lely AJ, Janssen JA, Uitterlinden P, Hofland LJ, Lamberts SW 1995 IGFBP-3 is a poor parameter for assessment of clinical activity in acromegaly. Clin Endocrinol (Oxf) 43:501-505
11. Freda PU, Post KD, Powell JS, Wardlaw SL 1998 Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J Clin Endocrinol Metab 83:3808-3816
12. Baxter RC 1997 The binding protein's binding protein-clinical applications of acid-labile subunit (ALS) measurement. J Clin Endocrinol Metab 82:3941-3943
13. Khosravi MJ, Diamandi A, Mistry J, Krishna RG, Khare A 1997 Acid-labile subunit of human insulin-like growth factor-binding protein complex: measurement, molecular, and clinical evaluation. J Clin Endocrinol Metab 82:3944-3951
14. Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, BarrecaA2001 Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3. J Clin Endocrinol Metab 86:1091-1098
15. Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG 2001 Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. J Clin Endocrinol Metab 86:3001-3008
16. Janssen JA, Lamberts SW 1999 Is the measurement of free IGF-I more indicative than that of total IGF-I in the evaluation of the biological activity of the GH/IGF-I axis? J Endocrinol Invest 22:313-315
17. Frystyk J, Skjaerbaek C, Dinesen B, Orskov H 1994 Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Lett 348:185-191
18. van der Lely AJ, de Herder WW, Janssen JA, Lamberts SW 1997 Acromegaly: the significance of serum total and free IGF-I and IGF-binding protein-3 in diagnosis. J Endocrinol 155(Suppl 1):S9 -S13; discussion S15-S16
19. Stoffel-Wagner B, Springer W, Bidlingmaier F, Klingmuller D 1997 A comparison of different methods for diagnosing acromegaly. Clin Endocrinol (Oxf) 46:531-537
20. Amit T, Youdim MB, Hochberg Z 2000 Clinical review 112: does serum growth hormone (GH) binding protein reflect human GH receptor function? J Clin Endocrinol Metab 85:927-932
21. Amit T, Ish-Shalom S, Glaser B, Youdim MB, Hochberg Z 1992 Growthhormone-binding protein in patients with acromegaly. Horm Res 37:205-211
22. Kratzsch J, Blum WF, Ventz M, Selisko T, Birkenmeyer G, Keller E 1995 Growth hormone-binding protein-related immunoreactivity in the serum of patients with acromegaly is regulated inversely by growth hormone concentration. Eur J Endocrinol 132:306-312
23. Hernandez I, Soderlund D, Espinosa-de-los-Monteros AL, Ochoa R, Zarate A, MercadoM1999 Differential effects of octreotide treatment and transsphenoidal surgery on growth hormone-binding protein levels in patients with acromegaly. J Neurosurg 90:647-650
24. Brabant G, von zur Muhlen A, Wuster C, Ranke MB, Kratzsch J, Kiess W, Ketelslegers JM, Wilhelmsen L, Hulthen L, Saller B, Mattsson A, Wilde J, Schemer R, Kann P 2003 Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 60:53-60
25. Juul A, Holm K, Kastrup KW, Pedersen SA, Michaelsen KF, Scheike T, Rasmussen S, Muller J, Skakkebaek NE 1997 Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 82:2497-2502
26. Stadler S, Wu Z, Dressendorfer RA, Morrison KM, Khare A, Lee PD, Strasburger CJ 2001 Monoclonal anti-acid-labile subunit oligopeptide antibodies and their use in a two-site immunoassay for ALS measurement in humans. J Immunol Methods 252:73-82
27. Carlsson LM, Rowland AM, Clark RG, Gesundheit N, Wong WL 1991 Ligand-mediated immunofunctional assay for quantitation of growth hormonebinding protein in human blood. J Clin Endocrinol Metab 73:1216-1223
28. Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD 2004 Significance of "abnormal" nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. J Clin Endocrinol Metab 89:495-500
29. Costa AC, Rossi A, Martinelli Jr CE, Machado HR, Moreira AC 2002 Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure? J Clin Endocrinol Metab 87:3142-3147
30. Vierhapper H, Heinze G, Gessl A, Exner M, Bieglmayr C 2003 Use of the oral glucose tolerance test to define remission in acromegaly. Metabolism 52:181-185
31. Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL 2002 Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab 87:3537-3542
32. Baumann G 1994 Growth hormone-binding proteins: state of the art. J Endocrinol 141:1-6
33. Baumann G, Shaw MA, AmburnK1994 Circulating growth hormone binding proteins. J Endocrinol Invest 17:67-81